Stereotaxis (NYSE:STXS) said earlier this week that its common stock has been approved for listing on the NYSE American exchange. After the company’s common stock ceased trading on the OTCQX when the market closed yesterday, it began trading on the NYSE at the open of trading today, under the same “STXS” symbol. The St. Louis, […]
Stereotaxis launches Genesis RMN robotic nav/imaging device, inks dev deal with Osypka, posts Q1 earnings
Stereotaxis (NSDQ:STXS) today released a slew of news including the launch of its Genesis RMN robotic navigation and imaging device, a collaborative deal with Osypka AG and its first quarter earnings. The St. Louis, Mo.-based company said that its Stereotaxis Genesis RMN is a next-gen robotic magnetic navigation system that uses smaller magnets designed to rotate along […]
CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018
CardioMech taps medtech veteran Nehm for CEO Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately. Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president […]
Stereotaxis, J&J’s BioSense Webster extend deal for magnetic ablation catheters
Stereotaxis (NSDQ:STXS) said today it extended a long-term deal with Johnson & Johnson’s (NYSE:JNJ) Biosense Webster to supply it with magnetic ablation catheters. With the extended deal, St. Louis-based Stereotaxis said it will continue to supply Biosense Webster’s catheters, and will continue to receive a royalty for the sale of those catheters. The deal includes Biosense Webster’s Navistar […]
Teva Pharma CEO Vigodman steps down | Personnel Moves | February 7, 2017
Teva Pharmaceuticals (NYSE:TEVA) said this week that CEO Erez Vigodman has stepped down from their position at the head of the world’s biggest generic drugmaker. Vigodman’s exit from the company will take effect immediately, with board chair Yitzhak Peterburg taking on the interim role of chief exec. Israel-based Teva has seen shares plummet after a series of […]
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest surgical robot players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find […]
Stereotaxis raises $24m
Medical robotics developer Stereotaxis (NSDQ:STXS) said yesterday it closed a $24 million private placement round, floating 24,000 shares of convertible preferred stock and warrants for the purchase of an aggregate 36.9 million shares of common stock. Each preferred share sold in the round is convertible at the option of the holder at a price of 65¢ per […]
Analyst: Medtronic most likely to challenge Intuitive Surgical in robot-assisted surgery
Medtronic (NYSE:MDT) is the most likely rival to Intuitive Surgical‘s (NSDQ:ISRG) dominance in the robot-assisted surgery space, but is still at least a year away from putting a competing device on the market, according to 1 analyst covering the medical device industry. Sunnyvale, Calif.-based Intuitive has a long lead, having had its flagship da Vinci system since 2000 and is […]
TAVI: Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves
Press Release: Stereotaxis receives FDA clearance of Vdrive with V-Loop system
Stereotaxis touts FDA win for robotic platform’s catheter manipulator
Missouri-based Stereotaxis (NSDQ:STXS) announced FDA clearance for its V-Loop product, the 2nd model from its Vdrive platform to make it to the U.S. market.
- 1
- 2
- 3
- 4
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube